Back to Woodline Partners LP Woodline Partners LP

MDGLMDGL

Showing 8 of 15 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Madrigal Pharmaceuticals, Inc.

Yes. Woodline Partners holds 125,899 shares of MDGL, worth $67.6M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held MDGL since Q1 2024, across 10 quarterly 13F filings. MDGL is 0.2% of Woodline Partners' reported 13F portfolio.

Current Value

$67.6M

Current Shares

125,899

Total Value Change

+$36.4M

Total Shares Change

-21,191

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
125,899
0.0%
$67.6M0.2%$536.95
0
2026-Q1
Increased
125,899
+0.2%
$65.9M0.2%$523.47
35
2025-Q4
Increased
125,659
+21.0%
$73.2M0.3%$582.34
42
2025-Q3
Decreased
103,847
-34.9%
$47.6M0.2%$458.66
0
2025-Q2
Decreased
159,623
-49.7%
$48.3M0.3%$302.64
0
2025-Q1
Increased
317,433
+2.7%
$105.1M0.7%$331.23
43
2024-Q4
Increased
309,117
+110.2%
$95.4M0.6%$308.57
68
2024-Q3
Increased
147,090
+6.3%
$31.2M0.3%$212.22
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used